Mark joined Keystone in 2026 as a Consultant I in the Boston office. Prior to joining Keystone, he was a biomedical engineer developing computational chemical imaging analysis platforms and neurotechnology devices for academic institutions and early-stage companies. While completing his graduate studies at Boston College, Mark worked with a strategic consulting firm specializing in pharmacovigilance and REMS, advising multinational pharmaceutical companies on their regulatory and post-market safety operations. This work led him to pursue additional coursework in health law and policy at Boston College Law School. Across these roles, he has led cross-functional projects bridging technical, regulatory, financial, and commercial stakeholders.
Outside of work, Mark is a New York sports fan who enjoys traveling, reading books on history and design, cooking different cuisines from around the world, and volunteering with science and engineering education initiatives.